Division of Vascular Surgery, University of Utah School of Medicine, Salt Lake City
Division of Vascular Surgery and Endovascular Therapy, University of Alabama- Birmingham
JAMA Surg. 2018 Mar 1;153(3):216-223. doi: 10.1001/jamasurg.2017.3942.
Ensuring that patients undergo surveillance imaging after surgery is a key quality metric after many vascular procedures. It is unclear whether hospital participation in a national quality improvement registry such as the Vascular Quality Initiative (VQI) achieves this goal.
To determine if hospital participation in the VQI registry is associated with increased rates of surveillance imaging after vascular procedures.
DESIGN, SETTING, AND PARTICIPANTS: A quasi-experimental study used Medicare claims to study 2174 US hospitals in which 1 530 102 patients had undergone an endovascular abdominal aortic aneurysm repair (EVAR), 1 403 067 patients had undergone a lower extremity bypass (LEB) or peripheral vascular intervention (PVI), and 294 942 patients had undergone carotid endarterectomy (CEA) and carotid artery stenting (CAS) procedures between January 1, 2007, and December 31, 2012. For each hospital, VQI participation was assessed, and a difference-in-differences analysis was used to measure the change in follow-up surveillance for VQI hospitals compared with control (non-VQI) hospitals selected after propensity score matching. The data were analyzed between January and August of 2016.
The proportion of patients who had imaging-based follow-up (computed tomography, duplex ultrasonography, or ankle-brachial index) within 1 year after their vascular procedure.
A total of 1 830 928 patients (947 139 women and 883 789 men; mean [SD] age, 75.8 [7.1] years) were identified across 2174 hospitals. Of 3 228 111 total vascular procedures, 1 403 067 patients (43.5%) underwent LEB or PVI, 1 530 102 patients (47.4%) underwent EVAR, and 294 942 patients (9.1%) underwent CEA or CAS. During the 6-year period, follow-up imaging rates varied between 50% and 53% after EVAR, between 52% and 58% after LEB or PVI, and between 74% and 78% after CEA or CAS. A total of 68 VQI participating hospitals were propensity-matched to 68 hospitals, and 279 446 patients were studied across these 136 hospitals. In difference-in-differences analyses, there was no significant improvement in follow-up imaging after joining VQI during year 1 (relative risk, 0.99; 95% CI, 0.97-1.01), year 2 (relative risk, 0.98; 95% CI, 0.95-1.01), or year 3 (relative risk, 0.99; 95% CI, 0.96-1.03). This association was consistent for patients undergoing EVAR, LEB or PVI, and CEA or CAS procedures.
Hospital participation in the VQI registry by itself does not increase rates of surveillance imaging after vascular procedures, suggesting that other strategies are needed to achieve this quality metric.
许多血管手术后,确保患者接受监测成像检查是一个关键的质量指标。目前尚不清楚医院参与国家质量改进注册,如血管质量倡议(VQI),是否能达到这一目标。
确定医院参与 VQI 注册是否与血管手术后监测成像率的增加有关。
设计、设置和参与者:一项准实验研究使用医疗保险索赔数据研究了美国 2174 家医院,其中 1530102 例患者接受了血管内腹主动脉瘤修复(EVAR),1403067 例患者接受了下肢旁路(LEB)或外周血管介入(PVI),294942 例患者接受了颈动脉内膜切除术(CEA)和颈动脉支架置入术(CAS)。在 2007 年 1 月 1 日至 2012 年 12 月 31 日期间,每家医院均评估了 VQI 的参与情况,并使用差异差异分析来衡量 VQI 医院与经倾向评分匹配后选择的对照(非 VQI)医院在随访监测方面的变化。数据分析于 2016 年 1 月至 8 月进行。
血管手术后 1 年内进行基于影像学的随访(计算机断层扫描、双功能超声或踝臂指数)的患者比例。
在 2174 家医院中,共确定了 1830928 例患者(947139 例女性和 883789 例男性;平均[SD]年龄为 75.8[7.1]岁)。在 3228111 例总血管手术中,1403067 例(43.5%)接受了 LEB 或 PVI,1530102 例(47.4%)接受了 EVAR,294942 例(9.1%)接受了 CEA 或 CAS。在 6 年期间,EVAR 后随访成像率在 50%至 53%之间,LEB 或 PVI 后在 52%至 58%之间,CEA 或 CAS 后在 74%至 78%之间。共有 68 家 VQI 参与医院与 68 家医院进行了倾向评分匹配,共有 279446 例患者在这 136 家医院进行了研究。在差异差异分析中,在第 1 年(相对风险,0.99;95%CI,0.97-1.01)、第 2 年(相对风险,0.98;95%CI,0.95-1.01)或第 3 年(相对风险,0.99;95%CI,0.96-1.03)加入 VQI 后,随访成像率没有显著改善。这一关联在接受 EVAR、LEB 或 PVI 和 CEA 或 CAS 手术的患者中是一致的。
医院本身参与 VQI 登记并不会增加血管手术后的监测成像率,这表明需要采取其他策略来实现这一质量指标。